Searching map area
Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial
? TBD
scientific article published on 17 July 2019
Nobody has rated this yet. Be the first!
Lists 0